Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-028-2 | CAS number: -
Acute Toxicity: other routes
Administrative data
- Endpoint:
- acute toxicity: other routes
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
Data source
Reference
- Title:
- Acute intraperitoneal LD50 in rat, Test n° 831156, TK 10417 (Irgafos TNPP)
- Author:
- Kobel
- Year:
- 1 983
- Bibliographic source:
- Ciba-Geigy Limited.
Materials and methods
- GLP compliance:
- not specified
- Limit test:
- yes
Test material
- Reference substance name:
- Tris(nonylphenyl) phosphite
- EC Number:
- 247-759-6
- EC Name:
- Tris(nonylphenyl) phosphite
- Cas Number:
- 26523-78-4
- Molecular formula:
- C45H69O3P
- IUPAC Name:
- Phenol, nonyl-, phosphite (3:1)
- Details on test material:
- other TS: Trisnonylphenyl phosphite
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Tif:RAIf(SPF)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS- Age at study initiation: 7-8 weeks - Weight at study initiation: 195 to 240 g
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- other: distilled water containing 0.5% carboxymethylcellulose and 0.1% polysorbate 80.
- Details on exposure:
- Single dose of 1000 mg/kg bw, by intraperitoneal injection.
- Doses:
- one single dose
- No. of animals per sex per dose:
- 10
- Control animals:
- other: needed for data submission
- Details on study design:
- - Duration of observation period following administration: Mortality and symptoms were observed daily for 14 days - Frequency of observations and weighing: 80 Animals were weighed at day 1, 7 and 14.- Necropsy of survivors performed: yes, the animals were submitted to a gross necropsy at the end of the observation period.
- Statistics:
- No data
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 1 000 mg/kg bw
- Mortality:
- No mortality occurred during the study.
- Clinical signs:
- Dyspnoea, exophtalmus, ruffled fur and curved body position were seen, being common symptoms in acute tests. Animals recovered within 12 days.
- Body weight:
- No data
- Gross pathology:
- At autopsy, peritoneal adhesions in the liver and spleen area were found in 8/10 animals.
Applicant's summary and conclusion
- Conclusions:
- LD50 (ip) >1000 mg/kg.
- Executive summary:
LD50 (ip) >1000 mg/kg.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
